The Evolving Landscape of Pigmentary Disorders: Insights from Leading Experts
During the 2024 Pigmentary Disorders Exchange Symposium, expert dermatologists discussed and shed light on the evolving therapeutic landscape of pigmentary disorders. They addressed key advances, challenges, and gaps in current knowledge. The panel, which was moderated by Dr. Pearl Grimes, featured Dr. John Harris, Dr. Thierry Passeron, and Dr. Ariel Kauvar.
Dr. Harris kicked off the panel disc …
During the 2024 Pigmentary Disorders Exchange Symposium, expert dermatologists discussed and shed light on the evolving therapeutic landscape of pigmentary disorders. They addressed key advances, challenges, and gaps in current knowledge. The panel, which was moderated by Dr. Pearl Grimes, featured Dr. John Harris, Dr. Thierry Passeron, and Dr. Ariel Kauvar.
Dr. Harris kicked off the panel disc … Continue reading "The Evolving Landscape of Pigmentary Disorders: Insights from Leading Experts"
Microneedling has emerged as a highly effective, minimally invasive technique for treating acne scars, revitalizing its status in dermatology through recent innovations. Unlike more aggressive treatments like laser resurfacing and deep chemical peels, microneedling offers significant advantages, particularly in terms of faster recovery (typically 2-3 days) and reduced risk of complications, even f … 
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition.1 Due to its longer duration of action, it is typically administered subcutaneously once weekly. The safety profile of semaglutide is similar to … 
Dermatologic procedures in children can be stressful for the patient, parent and the clinician. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Watch as Dr. Kirkorian shares four hot tips for procedures in kids. Find out why you might want to reconsider some … 
Alopecia areata (AA) is a nonscarring alopecia driven by autoreactive cytotoxic CD8 T cells against hair follicle antigens. With an unpredictable clinical course, which can include alopecia totalis and universalis, AA can be debilitating to patients’ quality of life. Historically, glucocorticosteroids, cyclosporine, methotrexate, and azathioprine were used off-label for non-targeted immunosuppre … 